PrimeRFP SCOUT · Federal Contract Recompete Brief

15B10626P00000273Specialty medication DOS: 4 3- 9 — Biologics, Inc

Biologics, Inc holds $32.9B across 6,499 federal awards, concentrated at Department of Justice (DOJ). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fmc Butner

Awarding office

Biologics, Inc

Recipient

Sep 30, 2026

PoP end

$286K

Obligated

$286K

Potential

325412

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Biologics, Inc — $90

Contract facts

NONE

Contract number15B10626P00000273

AgencyFmc Butner

Awarding officeFmc Butner

Awarding agencyDepartment of Justice (DOJ)

Funding agencyDepartment of Justice (DOJ)

IncumbentBiologics, Inc

CAGE6LEB9

UEIGVRYEDLFU6J3

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceCARY NC

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startApr 3, 2026

PoP end (current)Sep 30, 2026

Obligated$286K

Current value$286K

Potential value$286K

SPECIALTY MEDICATION DOS: 4/3- 9/30/2026 is a federal NONE award for Fmc Butner held by Biologics, Inc. Estimated value $286K ($286K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: CARY NC.

Recompete timing

Public

● Expiring in 23 days

Current PoP ends Sep 30, 2026 (23 days remaining). Agencies typically plan 12–18 months ahead — at 0.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Biologics, Inc — $32.9B obligated across 6,499 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).

% of firm-wide obligated ($32.9B) · all agencies

Department of Justice (DOJ)$571K · 0%Department of Veterans Affairs (VA)$136K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 15B10626P00000273?

15B10626P00000273 (Specialty medication DOS: 4 3- 9) is a Fmc Butner award with a potential value of $286K, currently held by Biologics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 15B10626P00000273?

Fmc Butner awarded 15B10626P00000273 to Biologics, Inc (potential $286K).

Who is the incumbent on 15B10626P00000273?

Biologics, Inc is the incumbent with $32.9B across 6499 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Biologics, Inc’s 15B10626P00000273 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 15B10626P00000273 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Apr 28, 2026